FISCAL NOTE
Date Requested: February 03, 2026
Time Requested: 05:13 PM |
| Agency: |
Insurance Commission |
|---|
| CBD Number: |
Version: |
Bill Number: |
Resolution Number: |
| 3372 |
Introduced |
HB5153 |
|
|---|
| CBD Subject: |
Health |
|---|
|
FUND(S):
7152
Sources of Revenue:
Special Fund
Legislation creates:
Fiscal Note Summary
Effect this measure will have on costs and revenues of state government.
House Bill 5153, if enacted, would provide insurance coverage for GLP-1 class medications with a valid script.
HB5153 would have no fiscal impact on the WV Offices of the Insurance Commissioner.
Please see memorandum summary for additional information.
Fiscal Note Detail
| Effect of Proposal |
Fiscal Year |
2026
Increase/Decrease
(use"-") |
2027
Increase/Decrease
(use"-") |
Fiscal Year
(Upon Full
Implementation) |
| 1. Estmated Total Cost |
0 |
0 |
0 |
| Personal Services |
0 |
0 |
0 |
| Current Expenses |
0 |
0 |
0 |
| Repairs and Alterations |
0 |
0 |
0 |
| Assets |
0 |
0 |
0 |
| Other |
0 |
0 |
0 |
| 2. Estimated Total Revenues |
0 |
0 |
0 |
Explanation of above estimates (including long-range effect):
Please explain increases and decreases in personal services, current expenses, repairs and alterations, assets, other costs and revenues, including assumptions and data sources and delineation between start-up and ongoing costs. Please also include a long-range schedule of costs and revenues if fiscal impact is expected to vary in future years.
Memorandum
House Bill 5153, if enacted, would provide insurance coverage for GLP-1 class medications with a valid script.
HB5153 would have no fiscal impact on the WV Offices of the Insurance Commissioner's operations, revenues or expenses.
HB5153 will have an impact on health coverage premium rates due to increase usage. The WV Offices of the Insurance Commissioner is aware of a nationwide Millman study that projects the costs at 1% of premium, but does not have the state specific data to estimate a local cost.
It should be noted that HB5153 does not contain language limiting the insurance benefits provided under the proposed bill to the essential health benefits (EHB) specified under section 130(b) of the Patient Protection and Affordable Care Act(PPACA). PPACA 1311 (d)(3) provides that a state must defray the cost by direct payment to enrollees or to the Plan of any state mandated benefit in excess of the EHB.
To the extent that the health insurance benefits required by HB5153 do not fall within the EHB, a potential costs to the State exists.
Person submitting Fiscal Note: Rhonda C Hartwell
Email Address: rc.hartwell@yahoo.com